Gregg Fergus

Celsee Diagnostics, Inc. develops, manufactures, and markets integrated comprehensive single-cell analysis solutions. It provides identification, analysis, and retrieves single cells from blood and tissue. The company was founded by Priyadarshini Gogoi, Saedeh Sepehri, and Christopher Siemer in 2011 and is headquartered in Ann Arbor, MI.

Celsee Diagnostics, Inc. develops, manufactures, and markets integrated comprehensive single-cell analysis solutions. It provides identification, analysis, and retrieves single cells from blood and tissue. The company was founded by Priyadarshini Gogoi, Saedeh Sepehri, and Christopher Siemer in 2011 and is headquartered in Ann Arbor, MI.

Celsee Diagnostics, Inc. develops, manufactures, and markets integrated comprehensive single-cell analysis solutions. It provides identification, analysis, and retrieves single cells from blood and tissue. The company was founded by Priyadarshini Gogoi, Saedeh Sepehri, and Christopher Siemer in 2011 and is headquartered in Ann Arbor, MI.

Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.

Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.

Celsee Diagnostics, Inc. develops, manufactures, and markets integrated comprehensive single-cell analysis solutions. It provides identification, analysis, and retrieves single cells from blood and tissue. The company was founded by Priyadarshini Gogoi, Saedeh Sepehri, and Christopher Siemer in 2011 and is headquartered in Ann Arbor, MI.

Celsee Diagnostics, Inc. develops, manufactures, and markets integrated comprehensive single-cell analysis solutions. It provides identification, analysis, and retrieves single cells from blood and tissue. The company was founded by Priyadarshini Gogoi, Saedeh Sepehri, and Christopher Siemer in 2011 and is headquartered in Ann Arbor, MI.

Live Undiscovered Music, Inc. engages in the development of a social music streaming application for emerging artists, listeners, and music curators. The company was founded by Max Ferguc, Gregg Fergus, and Will Ploch in 2018 and is headquartered in Madison, WI.

Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.

Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.

Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.